11-25-13 6:15 PM EST | Email Article

STEVENSON, Md., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of PhotoMedex, Inc. ("PhotoMedex" or the "Company") (Nasdaq:PHMD) common stock during the period between November 7, 2012 and November 14, 2013, inclusive (the "Class Period").

If you have suffered a net loss from investment in PhotoMedex, Inc. common stock purchased on or after November 7, 2012, and held through any of the revelations of negative information on October 17, 2103, November 6, 2013, and/or November 14, 2013, as described below, at no cost to you, you may obtain additional information about this lawsuit and your ability to become a lead plaintiff by contacting Brower Piven at www.browerpiven.com, by email at hoffman@browerpiven.com, by calling 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and class action cases of over 60 years.

No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff no later than January 21, 2014 and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants' failure to disclose during the Class Period that the effectiveness of the Company's key product, the no!no! device, rested on flimsy studies, that a more credible study showed that the no!no! device worked no better than shaving, and that the Company overstated its prospects for the no!no! device in the Japanese market. According to the complaint, following the October 17, 2013 report by TheStreetSweeper.org that raised serious concerns about the ineffectiveness and declining sales of the no!no! device, the Company's November 6, 2013 disclosure that there were no consumer sales to the Company's distributor in Japan in the third quarter of 2013, and the November 14, 2013 report by TheStreetSweeper.org which raised additional concerns about the effectiveness and sales of the no!no! device, the value of PhotoMedex shares declined significantly.

If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

CONTACT: Charles J. Piven
         Brower Piven, A Professional Corporation
         Stevenson, Maryland
         410/415-6616
         hoffman@browerpiven.com
GlobeNewswire, Inc. 2013
Add a Comment

News   More...

SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Fusion-io, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline (2013/12/5)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Tremor Video, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline (2013/12/5)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Quality Systems, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline ()
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Quality Systems, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline -- QSII (2013/11/21)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Fusion-io, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline -- FIO (2013/11/20)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in Tremor Video, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline -- TRMR (2013/11/26)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses From Investment in DFC Global Corp. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline -- DLLR (2013/11/21)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in DFC Global Corp. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline ()
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Violin Memory, Inc. to Contact Brower Piven Before the January 27, 2014 Lead Plaintiff Deadline (2013/12/5)
SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $100,000 in Losses from Investment in Violin Memory, Inc. to Contact Brower Piven Before the January 27, 2014 Lead Plaintiff Deadline (2014/1/6)
Securities related to this article
PhotoMedex, Inc. View phmd Stock Quote
PhotoMedex, Inc. View phmd Stock Quote
 
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Content Partners
Morningstar - - SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $50,000 in Losses From Investment in PhotoMedex, Inc. to Contact Brower Piven Before the January 21, 2014 Lead Plaintiff Deadline -- PHMD
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Author |  Collection |  Interest |  Popularity

Previous: SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $50,000 in Losses From Investment in General Cable Corporation to Contact Brower Piven Before the December 20, 2013 Lead Plaintiff Deadline -- BGC  |  Next: SHAREHOLDER ALERT: Brower Piven Encourages Investors With More Than $75,000 in Losses From Investment in BioScrip, Inc. to Contact Brower Piven Before the November 29, 2013 Lead Plaintiff Deadline